Rock Springs Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,100,000
Closed -$18.6M 119
2014
Q4
$18.6M Hold
1,100,000
2.18% 13
2014
Q3
$13.1M Buy
1,100,000
+400,000
+57% +$2.73M 2.03% 14
2014
Q2
$3.95M Buy
700,000
+400,000
+133% +$1.84M 0.71% 52
2014
Q1
$1.1M Hold
300,000
0.25% 71
2013
Q4
$1.01M Buy
+300,000
New +$1.24M 0.36% 60

Rock Springs Capital Management's AVNR Position: Q1 2015 in Review

Rock Springs Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,100,000 shares — an estimated $18.6M sold.

Rock Springs Capital Management first reported a position in AVNR in Q4 2013 and held it in 5 quarters. The position peaked at $18.6M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Rock Springs Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 1,100,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $18.6M.
  • Rock Springs Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2013 and held it in 5 quarters.
  • Rock Springs Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $18.6M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Rock Springs Capital Management's 13F filing for Q1 2015, filed 15 May 2015.